David et al.
SCHEME 1. Synthesis of
3-Phenoxybenzo[b]thiophene 1-Oxides
teoporosis. A structure-activity relationship study showed
that the replacement of the carbonyl group with an
oxygen resulted in a 10-fold increase in antiestrogen
potency both in vivo and in vitro.6 In addition, the
methoxy analogue, Arzoxifene, has improved bioavail-
ability compared with that of Raloxifene.7 Arzoxifene is
currently under investigation as a breast cancer therapy
in advanced disease.8
Substituted 2-arylbenzo[b]thiophenes are usually syn-
thesized by multistep intramolecular cyclization of thio-
phenol derivatives, according to the procedures of Kost,9
De,10 and Flynn.11 Nevertheless, these methods often
require many steps as well as acidic and/or basic condi-
tions which are not compatible with sensitive functional
groups. Surprisingly, little interest has been given to
direct access to substituted 2-arylbenzo[b]thiophenes
from benzo[b]thiophene. This paper describes a new and
rapid route to Arzoxifene analogues with heteroatoms at
the 3-positions. This synthetic approach is based on the
nucleophilic aromatic substitution (SNAr) of 3-bromo-
benzo[b]thiophene followed by a one-step Heck-type
coupling of the corresponding 3-substituted benzo[b]-
thiophenes with aryl halides.12,13
method described by our laboratory,19 we used a copper-
catalyzed aromatic nucleophilic substitution of 3-bromo-
benzo[b]thiophene by 2,2,2-trifluoroethanol to produce
3-(2,2,2-trifluoroethoxy)benzo[b]thiophene 1 in a 54%
yield. Nevertheless, assays with other nonfluorinated
alcohols, such as methanol, n-butanol, phenol, and benzyl
alcohol, failed.
As 3-bromo-2-nitrobenzo[b]thiophene reacted, probably
by an SNAr mechanism,20 with neutral and anionic
nucleophiles to give the expected 3-amino-2-nitrobenzo-
[b]thiophene, the activation of 3-bromobenzo[b]thiophene
seemed to be necessary. For the synthesis of Arzoxifene
and its derivatives, 2-aryl-3-bromobenzo[b]thiophene 1-ox-
ides underwent an SNAr reaction with both phenol and
thiophenol derivatives.6 Recently, De Nanteuil et al.21
performed the substitution of 2-carboxaldehyde-3-chloro-
5,6-disubstituted benzo[b]thiophenes with various phe-
nols. Therefore, we assumed that an electron-withdraw-
ing group at the 2-position of 3-bromobenzo[b]thiophene
as well as its oxidation into the corresponding sulfoxide
favors the nucleophilic displacement of bromide by
decreasing the charge density at the 3-position and
increasing the stabilization of the intermediate (probably
a Meisenheimer-like intermediate).
The use of 3-bromobenzo[b]thiophene 1-oxide 2 as the
starting material for the SNAr reaction allowed the direct
introduction of various phenols and secondary amines.
Commercially available 3-bromobenzo[b]thiophene12 was
oxidized at room temperature with hydrogen peroxide in
a trifluoroacetic acid and dichloromethane mixture to
produce 3-bromobenzo[b]thiophene 1-oxide 2 in a yield
of 85%.6
The SNAr reaction of compound 2 was then completed
with various phenolate salts formed in situ with K2CO3
as a base (Scheme 1). Reactions were carried out with 2
equiv of both alcohol and K2CO3 in DMF to favor
nucleophilic attack (Table 1).
Results and Discussion
SNAr. Few methods are described for the introduction
of an heteroatom at the 3-position of the benzo[b]-
thiophene core. Although Netchitailo14 synthesized 3-meth-
oxybenzo[b]thiophene by reaction of sodium methoxide
with 3-bromobenzo[b]thiophene, the reaction failed with
other substrates, such as phenol derivatives. The syn-
thesis of 3-(p-methoxyphenoxy)benzo[b]thiophene by the
copper iodide-catalyzed reaction of 3-bromobenzo[b]-
thiophene was reported with a very low yield.15
The Buchwald copper iodide-catalyzed amination16 and
etherification17 of aryl iodides and the Nolan18 amination
reaction of aryl halides were tested on 3-bromobenzo[b]-
thiophene. Unfortunately, they both failed. Following a
(6) Palkowitz, A. D.; Glasebrook, A. L.; Thrasher, K. J.; Hauser, K.
L.; Short, L. L.; Phillips, D. L.; Muehl, B. S.; Sato, M.; Shetler, P. K.;
Cullinan, G. J.; Pell, T. R.; Bryant, H. U. J. Med. Chem. 1997, 40,
1407.
(7) Sato, M.; Turner, C. H.; Wang, T.; Adrian, M. D.; Rowley, E.;
Bryant, H. U. J. Pharmacol. Exp. 1998, 287, 1.
(8) Munster, P. N.; Buzdar, A.; Dhingra, K.; Enas, N.; Ni, L.; Major,
M.; Melemed, A.; Seidman, A.; Booser, D.; Theriault, R.; Norton, L.;
Hudis, C. J. Clin. Oncol. 2001, 19, 2002.
(9) Kost, A. N.; Budylin, V. A.; Matveeva, E. D.; Sterligov, D. O.
Zh. Org. Khim. 1970, 6, 1503.
(10) Mukherjee, C.; Kamila, S.; De, A. Tetrahedron 2003, 59, 4767.
(11) Flynn, B. L.; Verdier-Pinard, P.; Hamel, E. Org. Lett. 2001, 3,
651.
Although total conversions were observed, partial
degradation of 3-bromobenzo[b]thiophene 1-oxide 2 oc-
curred at high temperature (during the reaction) produc-
ing only 60-80% isolated yields. As shown in Table 1,
the effectiveness of the SNAr reaction is influenced by
the electronic effects of the phenol substituents. Electron-
donating groups worked better than electron-withdraw-
ing groups in terms of the reaction temperatures and
(12) Fournier Dit Chabert, J.; Gozzi, C.; Lemaire, M. Tetrahedron
Lett. 2002, 43, 1829.
(13) Fournier Dit Chabert, J.; Joucla, L.; David, E.; Lemaire, M.
Tetrahedron 2004, 60, 3221.
(14) Netchitailo, P.; Decroix, B.; Morel, J.; Pastour, P. J. Heterocycl.
Chem. 1978, 15, 337.
(15) Sall, D. J.; Bailey, D. L.; Bastian, J. A.; Buben, J. A.; Chirgadze,
N. Y.; Clemens-Smith, A. C.; Denney, M. L.; Fisher, M. J.; Giera, D.
D.; Gifford-Moore, D. S.; Harper, R. W.; Johnson, L. M.; Klimkowski,
V. J.; Kohn, T. J.; Lin, H. S.; McCowan, J. R.; Palkowitz, A. D.; Richett,
M. E.; Smith, G. F.; Snyder, D. W.; Takeuchi, K.; Toth, J. E.; Zhang,
M. J. Med. Chem. 2000, 43, 649.
(16) Kwong, F. Y.; Klapars, A.; Buchwald, S. L. Org. Lett. 2002, 4,
581.
(19) El Kassmi, A.; Heraud, G.; Buchner, W.; Fache, F.; Lemaire,
M. J. Mol. Catal. 1992, 72, 299.
(17) Wolter, M.; Nordmann, G.; Job, G. E.; Buchwald, S. L. Org. Lett.
2002, 4, 973.
(20) Van Zyl, G.; Bredeweg, C. J.; Rynbrandt, R. H.; Neckers, D. C.
Can. J. Chem. 1966, 44, 2283.
(18) Grasa, G. A.; Viciu, M. S.; Huang, J.; Nolan, S. P. J. Org. Chem.
2001, 66, 7729.
(21) De Nanteuil, G.; Lila-Ambroise, C.; Rupin, A.; Vallez, M.-O.;
Verbeuren, T. J. Bioorg. Med. Chem. Lett. 2003, 13, 1705-1708.
3570 J. Org. Chem., Vol. 70, No. 9, 2005